John Gallagher
CONMED Corporation has appointed John E. Gallagher as chief financial officer, bringing in a seasoned healthcare and medical technology executive as the surgical device manufacturer continues executing growth initiatives across its portfolio of orthopedic and minimally invasive surgery products.
Gallagher will assume the role on July 15, succeeding Todd Garner, who will remain with the company in an advisory capacity through Nov. 2 to support the leadership transition.
The appointment comes as medical technology companies face increasing pressure to balance innovation investments, global expansion, supply chain management, and shareholder returns in a competitive healthcare environment. CFO roles have become increasingly strategic as public medtech companies pursue acquisitions, margin improvement programs, and international growth opportunities.
Patrick J. Beyer, president and CEO of CONMED, said Gallagher’s combination of healthcare industry expertise, public company leadership experience, and operational finance background made him a strong fit for the company’s next phase of growth.
Gallagher brings nearly 30 years of experience across corporate finance, treasury, investor relations, financial planning, accounting, and capital markets. Most recently, he served as CFO of Certara, a publicly traded pharmaceutical technology and services company that provides software and services supporting drug development.
Prior to Certara, he served as CFO of Cue Health, a healthcare technology company focused on diagnostic testing and digital health solutions.
A significant portion of Gallagher’s career was spent at Becton, Dickinson and Company (BD), where he held multiple senior leadership positions over nine years. He joined the company as corporate treasurer in 2012 and later expanded his responsibilities to include corporate finance, financial planning and analysis, and accounting functions. He also served as controller and chief accounting officer during two major acquisitions that reshaped the company’s portfolio.
In 2018, Gallagher was promoted to senior vice president and CFO of BD’s Medical Segment, the company’s largest business unit, where he worked closely with operational leadership on growth, profitability, and performance initiatives across a global medical technology portfolio.
Earlier in his career, Gallagher held finance leadership positions at General Electric and Ford Motor Company.
“I am excited to join CONMED and look forward to working closely with Pat and the rest of the CONMED team to further enhance the Company’s operating and financial performance,” Gallagher said.
The appointment reflects a broader trend across the medical technology sector, where companies increasingly seek finance leaders with both healthcare expertise and experience managing large-scale operational organizations. Investors have also placed greater emphasis on disciplined capital allocation, profitability improvement, and execution as the industry navigates shifting healthcare spending patterns and regulatory requirements.
Headquartered in Largo, Fla., CONMED Corporation develops and manufactures medical devices and surgical equipment used across orthopedics, general surgery, gynecology, thoracic surgery, and other specialties. The company competes in several high-growth surgical categories and has focused on expanding its portfolio through product innovation and strategic investments.
Gallagher holds a bachelor’s degree in finance from Clemson University and earned an MBA from the Joseph M. Katz Graduate School of Business at the University of Pittsburgh.
Leave a comment